Nucleoplasm Staining Patterns and Cell Cycle-associated Expression of Ki-67 in Middle Ear Cholesteatoma
Overview
Affiliations
Objectives: To compare Ki-67 expression patterns in middle ear cholesteatoma with the corresponding retroauricular and external auditory canal skins, and to determine the cell cycle-dependent localization of Ki-67.
Material And Methods: MIB-1 monoclonal antibody was used for comparative assessment of proliferative activity of middle ear cholesteatoma, external auditory canal skin, and retroauricular skin samples on formalin-fixed paraffin-embedded tissue sections. Primary keratinocytes from cholesteatoma tissue were isolated and subjected to kinetic analysis of the cell cycle.
Results: Higher proliferative activity was established in cholesteatoma in comparison with retroauricular and external auditory canal skins. Three different staining patterns have been described. Kinetic analysis revealed continuous expression of Ki-67 during all active phases of the cell cycle and remained "silent" in resting cells.
Conclusion: The established correlation between the staining patterns and cell cycle-associated expression of Ki-67 specifies Ki-67 as a reliable and stable marker of proliferation for middle ear cholesteatoma.
Recurrence in cholesteatoma surgery: what have we learnt and where are we going? A narrative review.
Bovi C, Luchena A, Bivona R, Borsetto D, Creber N, Danesi G Acta Otorhinolaryngol Ital. 2023; 43(Suppl 1):S48-S55.
PMID: 37698100 PMC: 10159641. DOI: 10.14639/0392-100X-suppl.1-43-2023-06.
Ozdemir C, Kuzu S, Senol Y, Yigit T, Guldun E, Bucak A Diagnostics (Basel). 2023; 13(3).
PMID: 36766559 PMC: 9914080. DOI: 10.3390/diagnostics13030455.
Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.
Araz Server E, Ertugay C, Baykal Koca S, Longur E, Yigit O, Demirhan H J Int Adv Otol. 2018; 15(1):38-42.
PMID: 30541725 PMC: 6483425. DOI: 10.5152/iao.2018.4976.
Zhang F, Guo F Exp Ther Med. 2018; 16(2):746-750.
PMID: 30116329 PMC: 6090253. DOI: 10.3892/etm.2018.6198.
Hamed M, Nakata S, Shiogama K, Suzuki K, Sayed R, Nishimura Y Clin Exp Otorhinolaryngol. 2017; 10(3):213-220.
PMID: 28073243 PMC: 5545701. DOI: 10.21053/ceo.2016.01263.